The disclosure relates to dihydroanthracene derivatives which possess analgesic activity, to processes for their manufacture and to compositions containing them. Typical of the dihydroanthracene derivatives disclosed is 6-chloro-4-hydroxy-1'-methyl-9,10-dihydroanthracene-9-spiro-4'-piperidine.